we tested the ability of nifedipine , a dihydropyridine class calcium channel blocker , to enhance the cytotoxicity of cisplatin , the current chemotherapeutic of choice against human head and neck tumors and testicular carcinoma .
C0028066
nifedipine
C2945601
dihydropyridine